Liangliang Wang
wangliangliang@mail.kib.ac.cn
Chinese, English, German, French
Yunnan
University of Chinese Academy of Sciences
Medical School
  • 2007-09--2012-07 PhD: Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences
  • 2003-09--2007-07 Bachelor of Science: Anhui University
  • 2023.06-present - Kunming Institute of Botany, Chinese Academy of Sciences - Researcher
  • 2017.03-2023.05 - Kunming Institute of Botany, Chinese Academy of Sciences - Associate Researcher
  • 2013-12-2016-12 - Leibniz Universität Hannover - Postdoctoral Researcher
  • 2013-11-2014-11 - École Polytechnique - Postdoctoral Researcher
Total synthesis of bioactive natural products and medicinal chemistry
Asymmetric synthesis methodologies based on metal or small organic molecule catalysis
  • Asymmetric Total Synthesis towards the Simplified Analogs of Antibiotic Elansolid A, Chinese Journal of Organic Chemistry, 2024
  • Chiral phosphoric acid catalyzed enantioselective inverse-electron-demand oxa-Diels-Alder reactions to synthesize chiral tricyclic tetrahydropyran derivatives, ORGANIC CHEMISTRY FRONTIERS, 2023
  • Asymmetric Total Synthesis of Antibiotic Elansolid A, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022
  • Enantioselective access to tricyclic tetrahydropyran derivatives by a remote hydrogen bonding mediated intramolecular IEDHDA reaction, NATURE COMMUNICATIONS, 2021
  • An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of Cathepsin L: KGP94, Bioorganic Chemistry, 2021
  • Biomimetic Intramolecular Diels-Alder Reaction to Construct the Tetrahydroindane Core of Elansolid A1/A2, Chinese Journal of Organic Chemistry, 2021
  • Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation, Computational Biology and Chemistry, 2021
  • An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94, BIOORGANIC CHEMISTRY, 2021
  • Biomimetic Intramolecular Diels-Alder Reaction to Construct the Tetrahydroindane Core of Elansolid A1/A2, 有机化学, 2021
  • The discovery, design and synthesis of potent agonists of adenylyl cyclase type 2 by virtual screening combining biological evaluation, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020
  • Discovery of a potent and selective adenylyl cyclase type 8 agonist by docking-based virtual screening, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020
  • Homology modeling and 3D-QSAR study of benzhydrylpiperazine δ opioid receptor agonists, Computational Biology and Chemistry, 2019
  • Identification of potential AMPK activator by pharmacophore modeling, molecular docking and QSAR study, Computational Biology and Chemistry, 2019
  • Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer invitro and invivo, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019
  • Homology modeling and 3D-QSAR study of benzhydrylpiperazine delta opioid receptor agonists, COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019
  • Asymmetric Syntheses of Spirooxindole-dihydroquinazolinones by Cyclization Reactions between N-substituted Anthranilamides and Isatins, ADV. SYNTH. CATAL, 2018
  • A bio-chemosynthetic approach to superparamagnetic iron oxide - ansamitocinconjugates for use in magnet drug targeting, Chem. Eur. J., 2017
  • Harnessing a p-Quinone Methide Intermediate in the Biomimetic Total Synthesis of the Highly Active Antibiotic 20-Deoxy-Elansolid B1, CHEMISTRY-A EUROPEAN JOURNAL, 2017
  • Organocatalytic stereocontrolled synthesis of 3,3 '-pyrrolidinyl spirooxindoles by 3+2 annulation of isocyanoesters with methyleneindolinones, CHEMICAL COMMUNICATIONS, 2012
  • A highly organocatalytic stereoselective double Michael reaction: efficient construction of optically enriched spirocyclic oxindoles, CHEMICAL COMMUNICATIONS, 2011
  • Highly organocatalytic asymmetric michael-ketone aldol-dehydration domino reaction: straightforward approach to construct six-membered spirocyclic oxindoles, CHEMICAL COMMUNICATIONS, 2010
Natural Products Total Synthesis Medicinal Chemistry Antibiotics Asymmetric Synthesis Metal Catalysis Organic Catalysis Chiral Synthesis Drug Candidates Structure Optimization

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.